Literature DB >> 7068353

Epidemiology of temporal arteritis in Israel.

G Friedman, B Friedman, J Benbassat.   

Abstract

An effort was made to identify all cases of biopsy-proven temporal arteritis (TA) diagnosed in Israel during 1960-78. A total of 46 Jewish patients was found, none of them under 50 yr of age. The age-standardized annual incidence rate of biopsy-proven TA among Jews in Israel rose from 1.6 in 1960-64 to 8.6 in 1975-78, with an overall incidence of 4.9 new cases diagnosed annually/10(6) population greater than or equal to 50 yr. The male:female ratio was 0.95. The annual incidence was 0.2 cases/10(6) population aged 50 to 59 yr, and 11.6/10(6) population greater than or equal to 70 yr of age. We feel that apparent increase in the incidence of TA is due to increased awareness of the disease rather than to an increase in morbidity.

Entities:  

Mesh:

Year:  1982        PMID: 7068353

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  8 in total

1.  Trends in the clinical presentation of temporal arteritis in Israel: reflection of increased physician awareness.

Authors:  G Nesher; A Rubinow; M Sonnenblick
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

2.  Aortic aneurysm and dissection are not associated with an increased risk for giant cell arteritis/ polymyalgia rheumatica.

Authors:  M Ehrenfeld; R Bitzur; J Schneiderman; A Smolinsky; Y Sidi; H Gur
Journal:  Postgrad Med J       Date:  2000-07       Impact factor: 2.401

3.  The sensation of facial swelling in temporal arteritis: a predictor for the development of visual disturbance.

Authors:  G Friedman; B Friedman
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

4.  Prolonged corticosteroid treatment in the management of temporal arteritis.

Authors:  G Friedman; B Friedman
Journal:  Klin Wochenschr       Date:  1988-12-01

5.  Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Artérite à Cellules Géantes.

Authors:  P Duhaut; L Pinède; H Bornet; S Demolombe-Ragué; C Dumontet; J Ninet; R Loire; J Pasquier
Journal:  Ann Rheum Dis       Date:  1999-06       Impact factor: 19.103

Review 6.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

Review 7.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

8.  The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.

Authors:  C M Weyand; K C Hicok; G G Hunder; J J Goronzy
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.